vascular biology
Recently Published Documents


TOTAL DOCUMENTS

617
(FIVE YEARS 71)

H-INDEX

62
(FIVE YEARS 8)

Stroke ◽  
2022 ◽  
pp. 3-10.e4
Author(s):  
T. Michael De Silva ◽  
Christopher G. Sobey

Stroke ◽  
2022 ◽  
pp. 138-152.e8
Author(s):  
Helen Kim ◽  
Ludmila Pawlikowska ◽  
Hua Su

2021 ◽  
Vol 22 (24) ◽  
pp. 13288
Author(s):  
Svitlana Demyanets ◽  
Stefan Stojkovic ◽  
Kurt Huber ◽  
Johann Wojta

In this review, we focus on the actual understanding of the role of IL-33 in vascular biology in the context of the historical development since the description of IL-33 as a member of IL-1 superfamily and the ligand for ST2 receptor in 2005. We summarize recent data on the biology, structure and signaling of this dual-function factor with both nuclear and extracellular cytokine properties. We describe cellular sources of IL-33, particularly within vascular wall, changes in its expression in different cardio-vascular conditions and mechanisms of IL-33 release. Additionally, we summarize the regulators of IL-33 expression as well as the effects of IL-33 itself in cells of the vasculature and in monocytes/macrophages in vitro combined with the consequences of IL-33 modulation in models of vascular diseases in vivo. Described in murine atherosclerosis models as well as in macrophages as an atheroprotective cytokine, extracellular IL-33 induces proinflammatory, prothrombotic and proangiogenic activation of human endothelial cells, which are processes known to be involved in the development and progression of atherosclerosis. We, therefore, discuss that IL-33 can possess both protective and harmful effects in experimental models of vascular pathologies depending on experimental conditions, type and dose of administration or method of modulation.


2021 ◽  
Vol 41 (10) ◽  
pp. 2513-2515
Author(s):  
Mireille Ouimet ◽  
Robert C. Bauer ◽  
Cynthia St. Hilaire

The pursuit of knowledge, curiosity about the natural world, and a drive to better the human condition are several of the many motivations that encourage someone to further their education in the biological sciences. However noble the intentions, success in an academic graduate program, and perhaps more importantly, in the career options that follow, is not guaranteed. While it is often said that a trainee needs support from their mentors and network to succeed, the Arteriosclerosis, Thrombosis and Vascular Biology Early Career Committee has observed, through our many interactions, both face to face and in the virtual space, that many trainees do not appreciate that building their mentoring network is an active process, and the trainee has more agency in the relationship than perhaps they perceive. In the article below, we discuss our views on building relationships and identifying mentors at different levels and for different purposes. We also highlight events hosted by the Arteriosclerosis, Thrombosis and Vascular Biology Early Career Committee at Vascular Discoveries, Scientific Sessions, and in the virtual space that can help you at the critical career stage.


Sign in / Sign up

Export Citation Format

Share Document